DEMI MERLINO: Open Payments
NPI 1144611922 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$744 in 40 payments from 15 companies in 2025. Trend: 2023 $1,159 · 2024 $690 · 2025 $744
Food & beverage: $744
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $230 |
| Amgen Inc. | 4 | $69 |
| Novo Nordisk Inc | 4 | $67 |
| PFIZER INC. | 4 | $57 |
| GlaxoSmithKline, LLC. | 4 | $56 |
| ABBVIE INC. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Exact Sciences Corporation | 2 | $34 |
| Dexcom, Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
Products named: AIRSUPRA, BREZTRI, Kerendia, PREVNAR 20, UBRELVY, REPATHA, Ozempic, Cologuard Collection Kit.
Industry payments across AR — which companies pay providers there.
